ri:val is a modular solution for the financial valuation and risk management of drug development projects, licenses, pipelines, technologies, companies, and investment portfolios.
The user-friendly framework guides you step-by-step through the valuation process. Save time and energy when looking for industry data or when building complex valuations in Excel because they’re built right in. ri:val allows modification and expansion of every valuation in any scenario. ri:val proposes all the relevant data for the valuation and can export all calculations into Excel.
ri:val standardizes and streamlines the valuation process and keeps topnotch valuation expertise at the fingertips of the entire team.
The results ensure a thorough understanding when making licensing decisions, when performing portfolio reviews, or when investing in biotech or pharma.
ri:val is your valuation expert when you license or invest in
To take advantage of ri:val software or to learn how ri:val can benefit you, contact us by phone or email us at firstname.lastname@example.org
Get on the ri:val mailing list and sign up for our email newsletter to discover what's new about ri:val and topical industry information.